About

VeloSano: "Swift Cure"

VeloSano is a year-round, community driven fundraising initiative with the mission to advance lifesaving cancer research at Cleveland Clinic. The flagship event is “Bike to cure” weekend taking place each July. 1OO% of the dollars raised through VeloSano directly supports the cause and in just four years, over $12.5 million is already hard at work in the fight against cancer.

1OO% for the cure

The ability to provide 1OO% of dollars raised to cancer research would not be possible without our Corporate and Foundation Partners. The financial and in-kind support they provide offsets all operational expenses allowing us to execute a safe, high-quality experience during "Bike to cure" weekend.

How VeloSano Works


Register

Join an existing team, start a new team or register individually. Whatever you choose, registration is the first step towards fighting cancer.

Raise

Ask your friends, family and network to donate to your fundraising commitment. You'll be surprised how quickly it adds up.

Ride

We have an option for everyone! Choose from 12 or 25 mile Fun Rides, 50, 75 or 100 mile Challenges or the Two-Day Ultimate Challenge.

Research

Every dollar raised by participants supports lifesaving cancer research at Cleveland Clinic.

Where the money goes.

At Cleveland Clinic Cancer Center, part of the NCCN and NCI-designated Case Comprehensive Cancer Center, more than 450 highly skilled doctors, researchers, nurses and technicians care for thousands of patients each year. Cleveland Clinic Cancer Center unites clinicians and researchers in Taussig Cancer Institute and in Cleveland Clinic's 26 other clinical and surgical institutes, as well as cancer specialists at regional hospitals, health centers and at Cleveland Clinic Florida. Ranked No. 1 in Ohio and No. 7 in the U.S. by U.S. News & World Report, Cleveland Clinic's Cancer Center provides a range of services to patients including clinical trials and internationally-recognized cancer research efforts ensuring patients have access to the latest advances in cancer treatment.

VeloSano is unique in that 1OO% of the dollars raised supports Cleveland Clinic's cancer research. Every mile that our participants ride, and every dollar that our donors give, is a reminder to Cleveland Clinic of their obligation to pursue research that will make a difference in patients’ lives.

Clinical Trials

Clinical trials are vital to the overall knowledge and progress against cancer. Most of today’s standard treatments for cancer began in clinical trials. It is through clinical trials that cancer researchers are able to test the effectiveness of new drugs compared to current therapy, pioneer new surgical techniques, and establish more precise screening tools.

With funding provided by VeloSano, we can offer more clinical trials designed by Cleveland Clinic researchers in the emerging areas of cancer genomics and immunotherapy to our patients, ensuring they have the best chance of success in beating cancer.

Genomics

The field of genomics is expanding rapidly – beyond simply identifying genes that predict a patient’s cancer risk. Oncologists are increasingly able to individualize a patient’s cancer treatment after identifying genetic mutations in a tumor – ones that may be absent from all the patient’s other cells.

In the future, it is possible that we will treat cancer by its underlying genomic make-up, rather than where it is located in the body. Cleveland Clinic is one of the first cancer centers in the nation to offer a genomics-based approach to cancer care.

Immunotherapy

Immunotherapy stimulates the body’s immune system to fight cancer. As tumor cells grow, they begin to produce proteins that shield themselves from a person’s immune system. Immunotherapy drugs are able to break that shield and stimulate the body’s immune system to attack the tumor cells.

Treatment for melanoma, an often deadly form of skin cancer, has been revolutionized by the introduction of new immunotherapy drugs. Cleveland Clinic is researching how this immunotherapy can help patients with other difficult-to-treat cancers, including bladder, brain, lung and kidney cancer.